2018/07/18 update
Presentation at the Japan Pharma & Governance Tour at UBS Securities
I was asked to join and present at a panel discussion organised by UBS Securities with the fund managers, to talk about the Japanese pharma market in general and also about the recent Takeda/Shire deal. I am sharing the slides that I used there, where I am discussing about the facts and implications of the recent pricing reform in Japan.
